Top Management Commitment

Message from the President

Promoting Sustainability Management to Achieve Sustained Growth

Sumitomo Pharma Group promotes "Sustainability Management" that balances the realization of a sustainable society with the enhancement of corporate value, guided by our corporate philosophy: "To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide."

Sustainability Management is important to integrate diverse and changing issues and needs of society into our business operations. We have positioned especially health-related challenges as our highest priority area of focus. We believe that the Group has a responsibility to continuously provide value toward the building of a healthy and vibrant society by creating innovative solutions to these health issues that only the Group can offer, not only to support the well-being of patients, but also to assist their families and caregivers.
We have positioned "Development of innovative products and healthcare solutions" as the most important among our Material Issues, which we identify based on the two axes of "expectations from society" and "impact on corporate value enhancement."

As outlined in our activity policy for FY2025 through FY2027, "Reboot 2027," announced in May 2025, we are aiming for a resurgence as a research-driven pharmaceutical company with bases in Japan and the United States. We are pursuing a wide range of new approaches— from small molecule drugs based on our cumulative experience and expertise to regenerative medicine & cell therapy utilizing technologies acquired through our pioneering efforts. Through these efforts, we aim to balance our business portfolio and contribute to all phases of the patient journey, from disease prevention to reintegration into society, as we strive to establish a unique global position as "Global Specialized Player."
The source of this innovation is our human resources. Our group has also identified "Expansion of human capital and instilment of corporate culture" as one of our priority issues. By maintaining and enhancing employee engagement and promoting the active participation of diverse talent, we aim to achieve individual and business growth, while continuously delivering value to society.

We are committed to creating innovative products and healthcare solutions that contribute most directly to Goal 3 "Good health and well-being" of the United Nations Sustainable Development Goals (SDGs). In addition, we are actively engaged in initiatives to fulfill our social responsibilities, including addressing urgent environmental challenges such as climate change (Goals 12 and 13), respecting the human rights of all our stakeholders including employees (Goal 10), and promoting compliance based on strong corporate ethics as a member of the life sciences industry (Goal 16). Thus, we will continue to contribute to a more sustainable society while striving for the sustained growth of the Sumitomo Pharma Group.

Finally, on behalf of Sumitomo Pharma, I would like to express my sincere gratitude to all stakeholders for your interest in the Company and ask for your continued understanding and support.